As a leading life sciences consulting firm offering strategic and
tactical commercialization services to pharmaceutical, biotechnology and
medical device manufacturers, D2
Consulting will participate at the upcoming Specialty
Pharmacy Summit in Las Vegas, Nevada. President and CEO, Dean
Erhardt, will present “Market Disintermediation: Mergers, Mega Players
and Media Hype,” Tuesday, April 30th, 10:30 a.m., Margaux
Room.
“We are honored to be presenting at this year’s Summit and interact with
the key players in the specialty pharmacy industry,” says Erhardt.
“During my presentation, attendees can expect to learn more about the
role of payers in the emerging value-based payment models for specialty
pharmacy as well as the impact on pharmaceutical and medical device
manufacturers for delivering value. The changing landscape that includes
emerging technology providers, new payer organizations resulting from
mergers and acquisitions, and new participants, requires greater
understanding of market changes. During this session, I will provide
guidance on how manufacturers might consider changing market dynamics.”
This 15th annual Specialty Pharmacy Summit welcomes
thousands of senior executives, key decision makers and other industry
professionals. Organizations being represented include pharmacies,
health systems, pharma/biotech manufacturers, drug wholesalers, health
plans, consulting firms, along with others.
Erhardt continues, “Discussions will include current perspectives,
collected via multiple industry interviews and interactions on the today
and tomorrow of a very changing market and how these changes might
impact product launch considerations. The complexities of a changing
market require innovative thinking, a fresh approach and the guidance of
experts who understand the nuances. Contract negotiations reflect a new
set of parameters and there’s simply no time for making avoidable
errors.”
To schedule a meeting with the D2 team, contact Darren
Steffano or visit Booth 501.
About D2 Consulting
D2 Consulting is a leading provider of commercialization services to the
healthcare and life sciences industries, D2 works across all
stakeholders including manufacturers, payers and channel participants to
execute strategic business initiatives that ensure successful launch,
distribution and reimbursement to maximize market impact and support an
ongoing leadership position in the marketplace. Visit http://d2rx.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190423005004/en/